MYC and diffuse large B-cell lymphoma: Besides, the excellent outcome of stage I MYC-R patients in our cohort is similar to outcomes of limited-stage DLBCL patients treated with R-CHOP(-like) regimens as described in earlier cohorts [18, 19].